We also manipulated the expression of EPAS1 as a second target as it was highly specific for ccRCC in our integrative analysis (Fig. 3B and Supplementary Fig. S8B), and prior studies have characterized its role in the pathogenesis of ccRCC51. This evidence concerns the gene EPAS1 and nonpapillary renal cell carcinoma.